EUVIMEDEUVIMED entdecken
Crossref

Protein–ligand interactions from a quantum fragmentation perspective: The case of the SARS-CoV-2 main protease interacting with α -ketoamide inhibitors

Luigi Genovese iD, William Dawson iD, Takahito Nakajima iD, Viviana Cristiglio iD, Valérie Vallet iD, Michel Masella iD

The Journal of Chemical Physics · 2023

DOI: 10.1063/5.0148064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Chemical Physics, 2023. Verfasst von Luigi Genovese und 5 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Grenoble Alpes, CEA, IRIG-MEM-L_Sim, 38000 Grenoble, France. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: CEA-Riken Collaboration, MaX EU Center of Excellence, French LabeX CaPPA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present a hybrid, multi-method, computational scheme for protein/ligand systems well suited to be used on modern and forthcoming massively parallel computing systems. The scheme relies on a multi-scale polarizable molecular modeling, approach to perform molecular dynamics simulations, and on an efficient Density Functional Theory (DFT) linear scaling method to post-process simulation snapshots. We use this scheme to investigate recent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2 virus. We assessed the reliability and the coherence of the hybrid scheme, in particular, by checking the ability of MM and DFT to reproduce results from high-end ab initio computations regarding such inhibitors. The DFT approach enables an a posteriori fragmentation of the system and an investigation into the strength of interaction among identified fragment pairs. We show the necessity of accounting for a large set of plausible protease/inhibitor conformations to generate reliable interaction data. Finally, we point out ways to further improve α-ketoamide inhibitors to more strongly interact with particular protease domains neighboring the active site.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansLigandsReproducibility of ResultsProtease InhibitorsCoronavirus 3C ProteasesMolecular Dynamics SimulationCatalytic DomainMolecular Docking Simulation

Substanzen

3C-like proteinase, SARS-CoV-2LigandsProtease InhibitorsCoronavirus 3C Proteases

Autor:innen und Institutionen

  • Univ. Grenoble Alpes, CEA, IRIG-MEM-L_Sim, 38000 Grenoble, France.
  • RIKEN Center for Computational Science, Kobe, Japan.
  • Institut Laue Langevin, 71 Av. des Martyrs, 38000 Grenoble, France.
  • Université de Lille, CNRS, UMR 8523 - PhLAM - Physique des Lasers Atomes et Molécules, F-59000 Lille, France.
  • Laboratoire de Biologie Structurale et Radiobiologie, Service de Bioénergétique, Biologie Structurale et Mécanismes, Institut Joliot, CEA Saclay, F-91191 Gif sur Yvette Cedex, France.

ORCID-Profile: Luigi Genovese, William Dawson, Takahito Nakajima, Viviana Cristiglio, Valérie Vallet, Michel Masella

Förderung

  • CEA-Riken Collaboration
  • MaX EU Center of Excellence
  • French LabeX CaPPA
  • ANR Project OVERSEE
  • CPER CLIMIBIO

Zitieren

APA

Genovese, L., Dawson, W., Nakajima, T., Cristiglio, V., Vallet, V., & Masella, M. (2023). Protein–ligand interactions from a quantum fragmentation perspective: The case of the SARS-CoV-2 main protease interacting with α -ketoamide inhibitors. The Journal of Chemical Physics. https://doi.org/10.1063/5.0148064

Vancouver

Genovese L, Dawson W, Nakajima T, Cristiglio V, Vallet V, Masella M. Protein–ligand interactions from a quantum fragmentation perspective: The case of the SARS-CoV-2 main protease interacting with α -ketoamide inhibitors. The Journal of Chemical Physics. 2023. doi:10.1063/5.0148064

BibTeX
@article{Genovese2023,
  author = {Genovese, Luigi and Dawson, William and Nakajima, Takahito and Cristiglio, Viviana and Vallet, Valérie and Masella, Michel},
  title = {Protein–ligand interactions from a quantum fragmentation perspective: The case of the SARS-CoV-2 main protease interacting with α -ketoamide inhibitors},
  journal = {The Journal of Chemical Physics},
  year = {2023},
  doi = {10.1063/5.0148064}
}
Kostenlos starten →